We have established three cellular markers to distinguish between human noninvasive benign colon adenomas and invasive colon carcinomas in primary culture. The biologically relevant tumor cells are assayed directly from resected tumors. Carcinoma cells are primary cultured from resected tumors free of lymphocytes, endothelial cells, and fibroblasts, and remain viable and dividing in tissue culture for 2-3 weeks. This relative longevity allows the carcinoma cells to be modulated in tissue culture, and transition to a more benign state measured by the markers developed. In initial experiments, the differentiation agent, hexamethylene bisacetamide (HMBA), induced differentiation of three tumors graded as moderately differentiated by histopathology; HMBA was ineffective on one poorly differentiated and two colloid colon carcinomas. We propose (1) to study the response of 20 primary cultured human colon carcinomas to HMBA by our in vitro assays; (2) to compare the effects of HMBA and TGFbeta on primary-cultured carcinomas; (3) to assay for terminal differentiation of normal colonic epithelial cells by TGFbeta; (4) to test the growth potential of the HMBA-treated cells both in vivo in the subrenal capsule assay in nude mice and in vitro by assay of the tumor growth fraction by continuous labeling with 3H-thymidine, (5) to begin studies to purify factor(s) secreted by HMBA-differentiated HT29 cells.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA045783-03
Application #
3189059
Study Section
Pathology B Study Section (PTHB)
Project Start
1987-07-01
Project End
1990-06-30
Budget Start
1989-07-01
Budget End
1990-06-30
Support Year
3
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Memorial Hospital for Cancer & Allied Di
Department
Type
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10021
Yan, Z; Chen, M; Perucho, M et al. (1997) Oncogenic Ki-ras but not oncogenic Ha-ras blocks integrin beta1-chain maturation in colon epithelial cells. J Biol Chem 272:30928-36
Yan, Z; Deng, X; Chen, M et al. (1997) Oncogenic c-Ki-ras but not oncogenic c-Ha-ras up-regulates CEA expression and disrupts basolateral polarity in colon epithelial cells. J Biol Chem 272:27902-7
Sauma, S; Yan, Z; Ohno, S et al. (1996) Protein kinase C beta 1 and protein kinase C beta 2 activate p57 mitogen-activated protein kinase and block differentiation in colon carcinoma cells. Cell Growth Differ 7:587-94
Sauma, S; Friedman, E (1996) Increased expression of protein kinase C beta activates ERK3. J Biol Chem 271:11422-6
Sauma, S; Huang, F; Winawer, S et al. (1995) Colon goblet cells lose proliferative response to TGF alpha as they differentiate. Int J Cancer 61:848-53
Huang, F; Sauma, S; Yan, Z et al. (1995) Colon absorptive epithelial cells lose proliferative response to TGF alpha as they differentiate. Exp Cell Res 219:8-14
Hsu, S; Huang, F; Friedman, E (1995) Platelet-derived growth factor-B increases colon cancer cell growth in vivo by a paracrine effect. J Cell Physiol 165:239-45
Friedman, E; Gold, L I; Klimstra, D et al. (1995) High levels of transforming growth factor beta 1 correlate with disease progression in human colon cancer. Cancer Epidemiol Biomarkers Prev 4:549-54
Hsu, S; Huang, F; Ossowski, L et al. (1995) Colon carcinoma cells with inactive nm23 show increased motility and response to motility factors. Carcinogenesis 16:2259-62
Huang, F; Newman, E; Theodorescu, D et al. (1995) Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid. Cell Growth Differ 6:1635-42

Showing the most recent 10 out of 19 publications